 |
A survey of 10 years of primary drug resistance in South Africa
SATuRN 2011 report, date: 2011 Manasa J, Cassol S, Seebregts C, Newell M-L, de Oliveira T
|
 |
Surveillance of Transmitted HIV-1 Drug Resistance in South African Provinces from 2005-2009
SATuRN 2011 report, date: 2011 Hunt GM, Ledwaba J, Basson AE, Moyes J, Cohen C, Singh B, Bertagnolio S, Jordan MR, Puren A and Morris L
|
 |
HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine
SATuRN 2011 report, date: 2011 Hunt GM, Coovadia A, Abrams EJ, Sherman G, Meyers T, Morris L and Kuhn L.
|
 |
Phenotypic Resistance to Etravirine in an HIV-1 Subtype-C Background
SATuRN 2011 report, date: 2011 AE Basson, S-Y Rhee, CM Parry, T de Oliveira, D Pillay, R Shafer and L Morris
|
 |
In adult patients failing a second-line protease inhibitor regimen lopinavir concentration measurement in plasma or hair are helpful to exclude patients with poor adherence from unnecessary resistance testing
SATuRN 2011 report, date: 2011 van Zyl GU, van Mens TE, McIlleron H, Zeier M, Nachega JB, Decloedt E, Malavazzi C, Smith P, Huang Y, van der Merwe L, Gandhi M, Maartens G.
|
 |
HIV clinical management: Integrating virtually failure clinics in southern Africa
SATuRN 2011 report, date: 2011 de Oliveira T, Rossouw T, Van Vuuren C, Naidu K, Ndwandwe L, Seebregts C
|
 |
Southern African HIV Drug Resistance and Clinical Management Workshop
SATuRN 2011 report, date: 2011 de Oliveira T, Seebregts C on behalf of SATuRN
|
|
|
SATuRN and Life Technologies (ABI) partnership provide a discounted HIV resistance genotyping system
SATuRN 2011 report, date: 2011 SATuRN / Life Technologies
|
 |
Southern African Treatment and Resistance Network (SATuRN) Executive Summary
SATuRN 2011 report, date: 2011 Tulio de Oliveira, Justen Manasa, Lungani Ndwandwe, Richard Lessells, David Katzenstein, Chris Seebregts
|
| SATuRN output, All reports... |
